2Invest AG
F:2INV
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.8
13.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
2Invest AG
2invest AG is a holding company, which engages in life sciences field and is primarily active in the areas of immunology, proteomics and genomics. The company is headquartered in Heidelberg, Baden-Wuerttemberg and currently employs 2 full-time employees. The company went IPO on 2000-08-10. 2invest AG acquires, holds, manages and sells investments in corporations and partnership in the biotechnology, life science and information technologies (IT) sectors in Germany and abroad.
2invest AG is a holding company, which engages in life sciences field and is primarily active in the areas of immunology, proteomics and genomics. The company is headquartered in Heidelberg, Baden-Wuerttemberg and currently employs 2 full-time employees. The company went IPO on 2000-08-10. 2invest AG acquires, holds, manages and sells investments in corporations and partnership in the biotechnology, life science and information technologies (IT) sectors in Germany and abroad.
